Detalles de la búsqueda
1.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(14): 1265-1276, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598794
2.
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
Mol Cancer
; 23(1): 126, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38862995
3.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271158
4.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Int J Clin Oncol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758397
5.
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Cancer Sci
; 114(2): 630-639, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285515
6.
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Cancer Sci
; 114(8): 3330-3341, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183528
7.
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Br J Cancer
; 129(12): 2003-2013, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731022
8.
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.
Cancer Immunol Immunother
; 72(8): 2613-2621, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062033
9.
Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance.
Jpn J Clin Oncol
; 53(7): 547-561, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279591
10.
Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression.
Cancer Immunol Immunother
; 71(3): 737-746, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389874
11.
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Cancer Immunol Immunother
; 71(2): 387-398, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34180007
12.
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Eur Respir J
; 60(6)2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361630
13.
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer.
Gastric Cancer
; 25(3): 619-628, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254550
14.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol
; 78(4): 613-621, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039908
15.
Medical management of older patients with lung cancer.
Jpn J Clin Oncol
; 52(10): 1082-1088, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975674
16.
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer.
Jpn J Clin Oncol
; 52(4): 383-387, 2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34999817
17.
Performance of Japanese patients in registrational studies.
Jpn J Clin Oncol
; 52(1): 53-64, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978326
18.
Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study.
Cancer Sci
; 112(8): 3255-3265, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036692
19.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 112(12): 5000-5010, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543477
20.
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
Br J Cancer
; 124(5): 925-932, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33250511